These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3281789)

  • 1. Drug dosing during continuous arteriovenous hemofiltration.
    Bickley SK
    Clin Pharm; 1988 Mar; 7(3):198-206. PubMed ID: 3281789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous arteriovenous hemofiltration: an alternative to hemodialysis.
    Horton MW; Godley PJ
    Am J Hosp Pharm; 1988 Jun; 45(6):1361-8. PubMed ID: 3046345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of vancomycin by continuous arteriovenous hemofiltration.
    Lau AH; John E
    Child Nephrol Urol; 1988-1989; 9(4):232-5. PubMed ID: 3255486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Elimination of drugs by hemofiltration. Principles and literature data].
    Hilt H; Keller F
    Anasth Intensivther Notfallmed; 1987 Dec; 22(6):278-82. PubMed ID: 3326424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous arteriovenous hemofiltration: a comparison with hemodialysis in acute renal failure.
    Kohen JA; Whitley KY; Kjellstrand CM
    Trans Am Soc Artif Intern Organs; 1985; 31():169-75. PubMed ID: 3837438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemofiltration: an alternative to dialysis.
    Paradiso C
    Heart Lung; 1989 May; 18(3):282-90. PubMed ID: 2722539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Continuous arteriovenous hemofiltration in acute renal failure. Value of regulating the rate of ultrafiltration].
    Milcent T; Toupance O; Lavaud S; Melin JP; Seys GA; Chanard J
    Nephrologie; 1985; 6(5):239-44. PubMed ID: 4094638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug dosage in patients during continuous renal replacement therapy. Pharmacokinetic and therapeutic considerations.
    Reetze-Bonorden P; Böhler J; Keller E
    Clin Pharmacokinet; 1993 May; 24(5):362-79. PubMed ID: 8504621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Techniques of continuous arteriovenous hemofiltration and hemodialysis. Renal replacement in the ICU for hypervolemic, uremic patients.
    Merrill RH
    J Crit Illn; 1991 Apr; 6(4):381-7. PubMed ID: 10147916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of theophylline clearance during continuous arteriovenous hemofiltration.
    Horton MW; Godley PJ; Moore ES; Fineg J; Gillespie WR
    Artif Organs; 1990 Dec; 14(6):416-20. PubMed ID: 2281990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics during continuous haemofiltration.
    Bressolle F; Kinowski JM; de la Coussaye JE; Wynn N; Eledjam JJ; Galtier M
    Clin Pharmacokinet; 1994 Jun; 26(6):457-71. PubMed ID: 8070219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
    Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
    Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal of cephalosporins by continuous arteriovenous ultrafiltration (CAVU) and hemofiltration (CAVH).
    Lau AH; Pyle K; Kronfol NO; Libertin CR
    Int J Artif Organs; 1989 Jun; 12(6):379-83. PubMed ID: 2777396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug administration in critically ill patients with acute renal failure.
    Kroh UF
    New Horiz; 1995 Nov; 3(4):748-59. PubMed ID: 8574606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous hemofiltration in patients with acute renal failure.
    Jerin L; Zuban F; Ladavac R; Bulić O
    Acta Med Croatica; 1995; 49(4-5):211-3. PubMed ID: 8630456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of continuous arteriovenous hemofiltration and intermittent hemodialysis in acute renal failure patients in the intensive care unit.
    Kruczynski K; Irvine-Bird K; Toffelmire EB; Morton AR
    ASAIO J; 1993; 39(3):M778-81. PubMed ID: 8268643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic principles and drug-dosing adjustments during continuous renal replacement therapies (CRRT)].
    Morabito S; Guzzo I; Vitaliano E; Muzi L; Solazzo A; Pistolesi V; Pierucci A
    G Ital Nefrol; 2006; 23 Suppl 36():S127-38. PubMed ID: 17068740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Principles of antibacterial dosing in continuous renal replacement therapy.
    Choi G; Gomersall CD; Tian Q; Joynt GM; Freebairn R; Lipman J
    Crit Care Med; 2009 Jul; 37(7):2268-82. PubMed ID: 19487930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug removal during continuous arteriovenous hemofiltration: theory and clinical observations.
    Golper TA; Wedel SK; Kaplan AA; Saad AM; Donta ST; Paganini EP
    Int J Artif Organs; 1985 Nov; 8(6):307-12. PubMed ID: 4077288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of intravenous cefuroxime during intermittent and continuous arteriovenous hemofiltration.
    Weiss LG; Cars O; Danielson BG; Grahnen A; Wikström B
    Clin Nephrol; 1988 Nov; 30(5):282-6. PubMed ID: 3214972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.